1. Home
  2. REVB vs CASK Comparison

REVB vs CASK Comparison

Compare REVB & CASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REVB
  • CASK
  • Stock Information
  • Founded
  • REVB 2020
  • CASK 2011
  • Country
  • REVB United States
  • CASK United States
  • Employees
  • REVB N/A
  • CASK N/A
  • Industry
  • REVB Biotechnology: Pharmaceutical Preparations
  • CASK
  • Sector
  • REVB Health Care
  • CASK
  • Exchange
  • REVB Nasdaq
  • CASK NYSE
  • Market Cap
  • REVB 5.4M
  • CASK 5.7M
  • IPO Year
  • REVB N/A
  • CASK 2024
  • Fundamental
  • Price
  • REVB $0.40
  • CASK $1.23
  • Analyst Decision
  • REVB
  • CASK
  • Analyst Count
  • REVB 0
  • CASK 0
  • Target Price
  • REVB N/A
  • CASK N/A
  • AVG Volume (30 Days)
  • REVB 6.8M
  • CASK 558.0K
  • Earning Date
  • REVB 11-08-2024
  • CASK 02-25-2025
  • Dividend Yield
  • REVB N/A
  • CASK N/A
  • EPS Growth
  • REVB N/A
  • CASK N/A
  • EPS
  • REVB N/A
  • CASK N/A
  • Revenue
  • REVB N/A
  • CASK $7,522,832.00
  • Revenue This Year
  • REVB N/A
  • CASK N/A
  • Revenue Next Year
  • REVB N/A
  • CASK N/A
  • P/E Ratio
  • REVB N/A
  • CASK $39.49
  • Revenue Growth
  • REVB N/A
  • CASK N/A
  • 52 Week Low
  • REVB $0.28
  • CASK $1.05
  • 52 Week High
  • REVB $25.26
  • CASK $4.00
  • Technical
  • Relative Strength Index (RSI)
  • REVB 39.87
  • CASK N/A
  • Support Level
  • REVB $0.39
  • CASK N/A
  • Resistance Level
  • REVB $0.53
  • CASK N/A
  • Average True Range (ATR)
  • REVB 0.13
  • CASK 0.00
  • MACD
  • REVB 0.00
  • CASK 0.00
  • Stochastic Oscillator
  • REVB 7.54
  • CASK 0.00

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About CASK HERITAGE DISTILLING HOLDING COMPANY INC

Heritage Distilling Holding Co Inc is a craft distiller producing, marketing and selling a diverse line of award-winning craft spirits, including whiskeys, vodkas, gins, rums, and ready-to-drink canned cocktails. The company sells its products through wholesale distribution, directly to consumers through its owned and operated distilleries and tasting rooms located in Washington and Oregon and by shipping directly to consumers online where legal. Currently, It sells products primarily in the Pacific Northwest with limited distribution in other states throughout the U.S.

Share on Social Networks: